133 related articles for article (PubMed ID: 979782)
1. The thalassaemias.
Med J Aust; 1976 Jul; 2(1):1-2. PubMed ID: 979782
[No Abstract] [Full Text] [Related]
2. Management of thalassaemia major.
Modell B; Petrou M
Arch Dis Child; 1983 Dec; 58(12):1026-30. PubMed ID: 6660889
[No Abstract] [Full Text] [Related]
3. Practical approaches to the control of thalassaemia.
Modell CB
Postgrad Med J; 1976; 52 Suppl 2():105-14. PubMed ID: 981108
[No Abstract] [Full Text] [Related]
4. Management of thalassaemia major.
Modell B
Br Med Bull; 1976 Sep; 32(3):270-6. PubMed ID: 788837
[No Abstract] [Full Text] [Related]
5. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
Kattamis C; Lagos P; Langona E
Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
[No Abstract] [Full Text] [Related]
6. [Hypertransfusion, chelating and immunocorrective therapy in beta-thalassemia major].
Zeĭnalova AA; Ragimov AA; Dashkova NG; Mamedova FR; Kurbanova SA
Pediatriia; 1987; (2):55-60. PubMed ID: 3575062
[No Abstract] [Full Text] [Related]
7. [Modern therapeutic possibilities in Cooley's disease].
Carcassi U
Atti Accad Fisiocrit Siena Med Fis; 1966; 15(2):1105-31. PubMed ID: 6001538
[No Abstract] [Full Text] [Related]
8. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia].
Esposito L; Ferrara M; Ponte G
Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088
[No Abstract] [Full Text] [Related]
9. Chelation therapy, transfusion requirement, and iron balance in young thalassemic patients.
Piomelli S; Graziano J; Karpatkin M; Dudell GG; Hart D; Hilgartner M; Khanna K; Valdes-Cruz LM; Vora S
Ann N Y Acad Sci; 1980; 344():409-17. PubMed ID: 6930881
[No Abstract] [Full Text] [Related]
10. [Use of desferrioxamine B in the treatment of post-transfusion hypersiderosis].
Orsini A; Giraud F; Bernard P; Passeron P
Mars Med; 1965; 102(7):591-5. PubMed ID: 5855127
[No Abstract] [Full Text] [Related]
11. Reduction of iron overload in thalassemia.
Piomelli S; Graziano J
Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
[No Abstract] [Full Text] [Related]
12. Cooley anemia: high transfusion regimen and chelation therapy, results, and perspective.
Weiner M; Karpatkin M; Hart D; Seaman C; Vora SK; Henry WL; Piomelli S
J Pediatr; 1978 Apr; 92(4):653-8. PubMed ID: 633033
[No Abstract] [Full Text] [Related]
13. Thalassemia.
Poncz M; Cohen A; Schwartz E
Adv Pediatr; 1984; 31():43-86. PubMed ID: 6516946
[No Abstract] [Full Text] [Related]
14. Iron chelating therapy in thalassemia: current problems.
Russo G
Haematologica; 1990; 75 Suppl 5():84-8. PubMed ID: 2086385
[No Abstract] [Full Text] [Related]
15. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.
Graziano JH; Piomelli S; Hilgartner M; Giardina P; Karpatkin M; Andrew M; LoIacono N; Seaman C
J Pediatr; 1981 Nov; 99(5):695-9. PubMed ID: 7299540
[TBL] [Abstract][Full Text] [Related]
16. The treatment of Cooley's anemia.
Nathan DG
Haematologica; 1990; 75 Suppl 5():57-65. PubMed ID: 2086382
[No Abstract] [Full Text] [Related]
17. Medical management of beta-thalassemia.
Lerner N
Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
[No Abstract] [Full Text] [Related]
18. Liver iron overload and liver fibrosis in thalassemia.
Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
[No Abstract] [Full Text] [Related]
19. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
Orsini A; Raybaud C; Bernard PJ; Aquaron R; Passeron P
Mars Med; 1967; 104(4):331-7. PubMed ID: 5621537
[No Abstract] [Full Text] [Related]
20. The management of the improved prognosis in thalassemia major.
Modell B
Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
